Hints and tips:
Related Special Reports
...Sanofi’s decision shows how mRNA has disrupted the once-staid vaccine business, leaving previously leading companies such as Sanofi and Merck racing to catch up....
...Before the pandemic, Sanofi was one of the world’s biggest vaccine makers by sales along with GlaxoSmithKline and Merck, but it slipped down the rankings last year as mRNA technology created new winners....
...“Music is now a utility . . . everyone’s happy to pay their $10 a month,” said Merck Mercuriadis, head of the acquisitive Hipgnosis Songs Fund that has gobbled up song catalogues in recent years at frothy...
...GSK, Merck and Sanofi shares have fallen between 13 and 30 per cent....
...Another French effort came to nothing in January when a Covid-19 vaccine out of the Pasteur Institute, which was later licensed to Merck, also failed in clinical trials....
...Sanofi shares have declined about 3 per cent since Hudson took over, while shares in rivals Merck and Pfizer are up about 0.6 per cent in the same period....
...Until now, the fastest vaccine ever created was a mumps vaccine developed by Merck in four years....
...It operates in 50 European cities under brands such as Merck Finck in Germany, InsingerGilissen in the Netherlands and Puilaetco Dewaay Private Bankers in Belgium. “I wanted to do something different....
...Pharma groups such as Merck and Pfizer, as well as Chinese players including Sinovac and Fosun, are all working on vaccines.Over the weekend, a European alliance led by Germany, France, Italy and the Netherlands...
...The acquisition comes after Merck’s success with Keytruda, a blockbuster drug that harnesses the immune system to fight cancer....
...Its shares had been underperforming its rivals, declining about 6 per cent in the five years to September 2019 when Mr Hudson arrived, compared with a 45 per cent rise for Merck and a 21 per cent rise for...
...Investors appear hopeful about the moves after several years in which Sanofi’s share performance has trailed rivals such as Merck and AstraZeneca....
...Quintet has about €70bn of assets under management and is a collection of seven boutique wealth management brands, including Brown Shipley in the UK and Merck Finck in Germany....
...Kenneth Frazier, chief executive of Merck, said prices would come down if the system was changed so that no one company faced a disadvantage....
...She was picking up Temodor, a Merck-made drug for her stage IV brain cancer, that usually cost her $75....
...Two — General Electric’s 2016 deal to buy LMD Wind and Merck of Germany’s 2014 takeover of Sigma-Aldrich — hinge on whether the buyer failed to disclose relevant research projects....
...Merck told the Financial Times that internal funding constraints would prevent the business reaching its “required scale . . ....
...I do think that’s a risk,” said Rob Davis, chief financial officer of Merck, in a recent interview with the Financial Times....
...Merck, the German drugmaker, recently announced its intention to explore a sale of its consumer division, which makes Seven Seas vitamins and nasal decongestants....
...The “big four” vaccine companies, GSK of the UK, Merck and Pfizer of the US and Sanofi of France, account for 80 per cent of global vaccine revenues, says a new Access to Vaccines Index issued by the Access...
...A range of companies has reported slowing or even falling sales in China, with Merck saying that its sales there fell 3 per cent in the first quarter....
...He added: “The good news is that momentum is there,” pointing to new accounts with companies such as HSBC and Merck, and retained mandates with Mars and Special K....
...Pfizer – one of the biggest drugmakers in the US – lost 2.4 per cent, while Merck fell 1.8 per cent. Johnson & Johnson shed 1.7 per cent and Eli Lilly lost 1.2 per cent....
...Shares in Pfizer, the world’s largest drugmaker by market value, had ended the week 8.6 per cent higher, while those in Allergan were up 6 per cent and Merck 5.7 per cent....
...The decision for Sanofi and Merck to part ways comes following a period of frenzied M&A activity in the global pharmaceuticals industry....
International Edition